SCHEMBL5507898

SCHEMBL5507898

CC(=CC(=O)O)C(C)(C)C

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.34
ATM Q13315 1/20 0.34
TSHR P16473 3/20 0.33
ALDH1A1 P00352 2/20 0.33
NR4A1 P22736 1/20 0.33
NR4A2 P43354 1/20 0.33
NR4A3 Q92570 1/20 0.33
FFAR3 O14843 1/20 0.33
LCK P06239 1/20 0.33
FYN P06241 1/20 0.33
MAPT P10636 1/20 0.31
PKM P14618 1/20 0.31
HTT P42858 1/20 0.31
RARA P10276 1/20 0.31
RARB P10826 1/20 0.31
RARG P13631 1/20 0.31
RXRA P19793 1/20 0.31
RXRB P28702 1/20 0.31
RXRG P48443 1/20 0.31
TP53 P04637 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5507895 1.00 KDM4E (0.34) KDM4EATMTSHRALDH1A1NR4A1
SCHEMBL10824467 0.80 ALDH1A1 (0.45) KDM4EATMTSHRALDH1A1NR4A1
SCHEMBL10824464 0.80 ALDH1A1 (0.45) KDM4EATMTSHRALDH1A1NR4A1
SCHEMBL11162927 0.79 ALDH1A1 (0.35) ALDH1A1
SCHEMBL11162924 0.79 ALDH1A1 (0.35) ALDH1A1
SCHEMBL1535991 0.77 MAPK1 (0.34) KDM4ETSHRALDH1A1MAPT
SCHEMBL1535989 0.77 MAPK1 (0.34) KDM4ETSHRALDH1A1MAPT
SCHEMBL14667919 0.76
SCHEMBL936907 0.74 NR4A1 (0.41) KDM4EATMNR4A1NR4A2NR4A3
SCHEMBL20939073 0.74 LMNA (0.37) TSHRALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 186 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114868298-B Composite stripping method Guangdong Haozhi Technology Co.,Ltd. (CN) 2026-05-26 CN claimed
US-12605926-B2 Binder composition for secondary battery GRST SINGAPORE PTE. LTD. (SG) 2026-04-21 US claimed
EP-4169110-B1 METHOD FOR COMPOSITE DELAMINATION GRST SINGAPORE PTE LTD (SG) 2026-04-15 EP claimed
EP-4169106-B1 METHOD FOR COMPOSITE DELAMINATION GRST SINGAPORE PTE LTD (SG) 2026-04-01 EP claimed
EP-4169108-B1 METHOD FOR COMPOSITE DELAMINATION GRST SINGAPORE PTE LTD (SG) 2025-12-03 EP claimed
US-12431502-B2 Binder composition for secondary battery GRST SINGAPORE PTE. LTD. (SG) 2025-09-30 US claimed
US-12410265-B2 Method for polymer precipitation GRST SINGAPORE PTE. LTD. (SG) 2025-09-09 US claimed
US-12404356-B2 Method for composite delamination GRST SINGAPORE PTE. LTD. (SG) 2025-09-02 US claimed
US-12401040-B2 Binder composition for secondary battery GRST SINGAPORE PTE. LTD. (SG) 2025-08-26 US claimed
US-12358275-B2 Method for composite delamination GRST SINGAPORE PTE. LTD. (SG) 2025-07-15 US claimed
CN-114846654-A Method for precipitating a polymer 广东省皓智科技有限公司 2022-08-02 CN claimed
CN-114503336-A Method for stripping composite 广东省皓智科技有限公司 2022-05-13 CN claimed
CN-114424365-A Cathode for secondary battery and cathode slurry 广东省皓智科技有限公司 2022-04-29 CN claimed
CN-114342125-A Binder composition for secondary battery 广东省皓智科技有限公司 2022-04-12 CN claimed
CN-114342124-A Binder composition for secondary battery 广东省皓智科技有限公司 2022-04-12 CN claimed
CN-114341304-A Binder composition for secondary battery 广东省皓智科技有限公司 2022-04-12 CN claimed
CN-114287074-A Binder composition for secondary battery 广东省皓智科技有限公司 2022-04-05 CN claimed
US-4774342-A ANTITUMOR AGENTS SUNTORY LIMITED (JP) 1988-09-27 US claimed
EP-0108645-B1 NOVEL AILANTHONE DERIVATIVE SUNTORY LIMITED (JP) 1987-05-13 EP claimed
EP-0108645-A2 Novel ailanthone derivative SUNTORY LIMITED (JP) 1984-05-16 EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12605926-B2 Binder composition for secondary battery CA1, CA3, CA6 KDM4E 3634/4885ATM 3132/4885TSHR 1124/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.